B2635
Busulfan
analytical standard, for drug analysis
Synonym(s):
1,4-Butanediol dimethanesulfonate
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
CH3SO2O(CH2)4OSO2CH3
CAS Number:
Molecular Weight:
246.30
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
EC Number:
200-250-2
Beilstein/REAXYS Number:
1791786
MDL number:
Quality Level
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
mp
114-117 °C (lit.)
application(s)
forensics and toxicology
veterinary
format
neat
SMILES string
CS(=O)(=O)OCCCCOS(C)(=O)=O
InChI
1S/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3
InChI key
COVZYZSDYWQREU-UHFFFAOYSA-N
General description
Busulfan is a bifunctional alkylating agent, which may find application in the treatment of chronic granulocytic leukemia.
Application
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
Still not finding the right product?
Explore all of our products under Busulfan
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Oral - Carc. 1A - Muta. 1B - Repr. 1B
Storage Class
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Blood and Marrow Stem Cell Transplantation: Principles, Practice, and Nursing Insights (1997)
Manabu Ozawa et al.
Biology of reproduction, 94(4), 92-92 (2016-03-18)
The F-box and leucine-rich repeat protein 10 (Fbxl10) gene encodes a protein that catalyzes demethylation of H3K4 and H3K36. In this study, we show the important roles of FBXL10 as a histone demethylase in sustainable sperm production using mice in
Christopher Bredeson et al.
Blood, 122(24), 3871-3878 (2013-10-02)
We conducted a prospective cohort study testing the noninferiority of survival of ablative intravenous busulfan (IV-BU) vs ablative total body irradiation (TBI)-based regimens in myeloid malignancies. A total of 1483 patients undergoing transplantation for myeloid malignancies (IV-BU, N = 1025;
Global Trade Item Number
| SKU | GTIN |
|---|---|
| B2635-25G | 04061833426982 |
| B2635-10G | 04061833426975 |